Skip to content

About
Science
- Overview
- Publications
Pipeline
Investors
Careers
Contact

About
Science
- Overview
- Publications
Pipeline
Investors
Careers
Contact

Press Releases

Choose Year
Search Press Releases

Found 83 Results

November 15, 2021

Surrozen Reports Third Quarter 2021 Financial Results

November 15, 2021

Surrozen to Present at The Piper Sandler 33rd Annual Healthcare Conference

November 15, 2021

Surrozen Presents Data Supporting Potential of SZN-043 at The Liver Meeting 2021,the Annual Meeting of the American Association for the Study of Liver Diseases

November 5, 2021

Surrozen to Present at The Stifel 2021 Virtual Healthcare Conference

October 5, 2021

Surrozen Presented Data Supporting Potential of SZN-1326 at the 2021 United European Gastroenterology Week

September 23, 2021

Surrozen Announces Appointment of Liz Nguyen as Vice President and Head of Human Resources

August 11, 2021

Surrozen Debuts as Publicly Traded Leader in Wnt Biology and Tissue Regeneration

August 5, 2021

Surrozen to Present at Canaccord Genuity’s 41st Annual Growth Conference

July 9, 2021

Surrozen Presents New Data Demonstrating Superior Activity of SZN-1326 in Preclinical Inflammatory Bowel Disease Models at 16th Congress of the European Crohn’s and Colitis Organisation (ECCO)

June 25, 2021

Surrozen Presents Data at 2021 International Liver Conference for Wnt-Modulating Antibody SZN-043

«...4 567 8...»

IR Contact

Email: investorinfo@surrozen.com

Email Alerts Sign-Up

Email

Unsubscribe

Loading...

Company

About
Management
Board of Directors
Scientific Advisors
Contact
Careers

Science

Science
Pipeline
Publications

Investors

Overview
News
Events
SEC Filings
Corporate Governance
Stock Information
FAQs

Copyright © 2026 Surrozen. All Rights Reserved

FCOI Policy
Accessibility

Scroll to Top